These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 17332365)

  • 1. Fractalkine (CX3CL1)- and interleukin-2-enriched neuroblastoma microenvironment induces eradication of metastases mediated by T cells and natural killer cells.
    Zeng Y; Huebener N; Fest S; Weixler S; Schroeder U; Gaedicke G; Xiang R; Schramm A; Eggert A; Reisfeld RA; Lode HN
    Cancer Res; 2007 Mar; 67(5):2331-8. PubMed ID: 17332365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractalkine gene therapy for neuroblastoma is more effective in combination with targeted IL-2.
    Zeng Y; Jiang J; Huebener N; Wenkel J; Gaedicke G; Xiang R; Lode HN
    Cancer Lett; 2005 Oct; 228(1-2):187-93. PubMed ID: 15953676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells modified to express fractalkine/CX3CL1 in the treatment of preexisting tumors.
    Nukiwa M; Andarini S; Zaini J; Xin H; Kanehira M; Suzuki T; Fukuhara T; Mizuguchi H; Hayakawa T; Saijo Y; Nukiwa T; Kikuchi T
    Eur J Immunol; 2006 Apr; 36(4):1019-27. PubMed ID: 16525992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells.
    Xin H; Kikuchi T; Andarini S; Ohkouchi S; Suzuki T; Nukiwa T; Huqun ; Hagiwara K; Honjo T; Saijo Y
    Eur J Immunol; 2005 May; 35(5):1371-80. PubMed ID: 15789339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of interaction between Fractalkine and CX3CR1 in cytotoxicity of natural killer cells against tumor cells.
    Zhang X; Wei H; Wang H; Tian Z
    Oncol Rep; 2006 Feb; 15(2):485-8. PubMed ID: 16391873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular mechanisms of interleukin-12-mediated neuroblastoma regression.
    Redlinger RE; Shimizu T; Remy T; Alber S; Watkins SC; Barksdale EM
    J Pediatr Surg; 2003 Feb; 38(2):199-204. PubMed ID: 12596103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses.
    Fraticelli P; Sironi M; Bianchi G; D'Ambrosio D; Albanesi C; Stoppacciaro A; Chieppa M; Allavena P; Ruco L; Girolomoni G; Sinigaglia F; Vecchi A; Mantovani A
    J Clin Invest; 2001 May; 107(9):1173-81. PubMed ID: 11342581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of human natural killer cells by recombinant membrane-expressed fractalkine on the surface of tumor cells.
    Zhang X; Wei H; Chen Q; Tian Z
    Oncol Rep; 2007 Jun; 17(6):1371-5. PubMed ID: 17487393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis.
    Sawai H; Park YW; Roberson J; Imai T; Goronzy JJ; Weyand CM
    Arthritis Rheum; 2005 May; 52(5):1392-401. PubMed ID: 15880821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic interleukin-18 and low-dose interleukin-2 promote regression of established murine neuroblastoma in vivo.
    Redlinger RE; Mailliard RB; Lotze MT; Barksdale EM
    J Pediatr Surg; 2003 Mar; 38(3):301-7; discussion 301-7. PubMed ID: 12632339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation.
    Echigo T; Hasegawa M; Shimada Y; Takehara K; Sato S
    J Allergy Clin Immunol; 2004 May; 113(5):940-8. PubMed ID: 15131578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fractalkine mediates natural killer-dependent antitumor responses in vivo.
    Lavergne E; Combadière B; Bonduelle O; Iga M; Gao JL; Maho M; Boissonnas A; Murphy PM; Debré P; Combadière C
    Cancer Res; 2003 Nov; 63(21):7468-74. PubMed ID: 14612547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs.
    Brignole C; Pastorino F; Marimpietri D; Pagnan G; Pistorio A; Allen TM; Pistoia V; Ponzoni M
    J Natl Cancer Inst; 2004 Aug; 96(15):1171-80. PubMed ID: 15292389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity.
    Hwang KS; Cho WK; Yoo J; Seong YR; Kim BK; Kim S; Im DS
    Cancer Gene Ther; 2004 Jun; 11(6):397-407. PubMed ID: 15044962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation.
    Martí F; Pardo N; Peiró M; Bertran E; Amill B; García J; Cubells J; Rueda F
    Exp Hematol; 1995 Dec; 23(14):1445-52. PubMed ID: 8542930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractalkine in vascular biology: from basic research to clinical disease.
    Umehara H; Bloom ET; Okazaki T; Nagano Y; Yoshie O; Imai T
    Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):34-40. PubMed ID: 12969992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-neuroblastoma effect of ch14.18 antibody produced in CHO cells is mediated by NK-cells in mice.
    Zeng Y; Fest S; Kunert R; Katinger H; Pistoia V; Michon J; Lewis G; Ladenstein R; Lode HN
    Mol Immunol; 2005 Jul; 42(11):1311-9. PubMed ID: 15950727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and tumorigenicity of human neuroblastoma cells transfected with the IL-2 gene.
    Corrias MV; Basso S; Meazza R; Musiani P; Santi L; Bocca P; Occhino M; Ferrini S; Pistoia V
    Cancer Gene Ther; 1998; 5(1):38-44. PubMed ID: 9476965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane-bound form of fractalkine induces IFN-gamma production by NK cells.
    Yoneda O; Imai T; Nishimura M; Miyaji M; Mimori T; Okazaki T; Domae N; Fujimoto H; Minami Y; Kono T; Bloom ET; Umehara H
    Eur J Immunol; 2003 Jan; 33(1):53-8. PubMed ID: 12594832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-12 transduced dendritic cells induce regression of established murine neuroblastoma.
    Shimizu T; Berhanu A; Redlinger RE; Watkins S; Lotze MT; Barksdale EM
    J Pediatr Surg; 2001 Aug; 36(8):1285-92. PubMed ID: 11479878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.